(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

FORMAS CRISTALINAS DE UM AGONISTA DE RECEPTOR FARNESOIDE X

ArquivadaInvention PatentPCT · US2019051605

Application data

Number

112021004931

Type

Invention Patent

Filing

09/17/2019

Publication

06/01/2021

PCT

US2019051605

Progress at the INPI

  1. Filing09/17/19
  2. Publication06/01/21
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: examination was not requested within the 36 months following the 09/17/2019 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 03/14/2023. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

METACRINE, INC.

US

Inventors

N. S. (pessoa física)

US

R. M. (pessoa física)

US

Technical data

Priority claims

US

62/733,007 · 09/18/2018

Abstract

FORMAS CRISTALINAS DE UM AGONISTA DE RECEPTOR FARNESOIDE X.É descrito no presente documento o agonista de receptor farnesoide X, trans-N-(3-(1-ciclopropil-1H-pirazol-4-il)fenil)-4-hidroxi-N-((trans-4-(4-metoxi-3-metilfenil)ciclo-hexil)metil)ciclo-hexanocarboxamida, incluindo formas cristalinas e sais, solvatos farmaceuticamente aceitáveis, e formulações da mesma.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento definitivo - Art. 33 da LPI

#11.1.1

03/14/2023

RPI 2723

Arquivamento - Art. 33 da LPI

#11.1

12/27/2022

RPI 2712

Notificação de entrada na fase nacional - PCT

#1.3

06/01/2021

RPI 2630

Alteração de dados cadastrais

#1.1

03/23/2021

RPI 2620

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.